IL236710B - Process for preparing 17-disubstituted derivatives of 3-oxy-6-oxo-8,7-didhydro-14-hydroxy-morphinan sulfates - Google Patents

Process for preparing 17-disubstituted derivatives of 3-oxy-6-oxo-8,7-didhydro-14-hydroxy-morphinan sulfates

Info

Publication number
IL236710B
IL236710B IL236710A IL23671015A IL236710B IL 236710 B IL236710 B IL 236710B IL 236710 A IL236710 A IL 236710A IL 23671015 A IL23671015 A IL 23671015A IL 236710 B IL236710 B IL 236710B
Authority
IL
Israel
Prior art keywords
morphinan
didehydro
sulfates
oxy
oxo
Prior art date
Application number
IL236710A
Other languages
English (en)
Hebrew (he)
Other versions
IL236710A0 (en
Original Assignee
Rhodes Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodes Tech filed Critical Rhodes Tech
Publication of IL236710A0 publication Critical patent/IL236710A0/en
Publication of IL236710B publication Critical patent/IL236710B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
IL236710A 2012-07-16 2015-01-13 Process for preparing 17-disubstituted derivatives of 3-oxy-6-oxo-8,7-didhydro-14-hydroxy-morphinan sulfates IL236710B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261672260P 2012-07-16 2012-07-16
US201261741480P 2012-07-19 2012-07-19
US201361762637P 2013-02-08 2013-02-08
PCT/IB2013/001541 WO2014013313A1 (en) 2012-07-16 2013-07-15 Process for improved opioid synthesis

Publications (2)

Publication Number Publication Date
IL236710A0 IL236710A0 (en) 2015-02-26
IL236710B true IL236710B (en) 2018-04-30

Family

ID=48916127

Family Applications (1)

Application Number Title Priority Date Filing Date
IL236710A IL236710B (en) 2012-07-16 2015-01-13 Process for preparing 17-disubstituted derivatives of 3-oxy-6-oxo-8,7-didhydro-14-hydroxy-morphinan sulfates

Country Status (21)

Country Link
US (3) US10316042B2 (forum.php)
EP (1) EP2872516B1 (forum.php)
JP (1) JP6236447B2 (forum.php)
KR (1) KR101946103B1 (forum.php)
CN (1) CN104470928B (forum.php)
AR (1) AR092858A1 (forum.php)
AU (2) AU2013291725B2 (forum.php)
BR (1) BR112015000944A2 (forum.php)
CA (2) CA2879270C (forum.php)
CO (1) CO7180188A2 (forum.php)
EA (1) EA028092B1 (forum.php)
ES (1) ES2647949T3 (forum.php)
IL (1) IL236710B (forum.php)
IN (1) IN2015DN01165A (forum.php)
MX (1) MX363610B (forum.php)
NZ (1) NZ628699A (forum.php)
PH (1) PH12015500089A1 (forum.php)
SG (1) SG11201407988UA (forum.php)
TW (2) TWI643859B (forum.php)
UA (1) UA117225C2 (forum.php)
WO (1) WO2014013313A1 (forum.php)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5923827B2 (ja) * 1981-12-16 1984-06-05 フエザ−安全剃刀株式会社 安全かみそり刃
WO2014013311A1 (en) 2012-07-16 2014-01-23 Rhodes Technologies Process for improved opioid synthesis
BR112016002079A2 (pt) * 2013-08-02 2017-09-05 Johnson Matthey Plc Processo para preparação de um aditivo ácido de oximorfona, solução aquosa de aditivo ácido de oximorfona, aditivo ácido de oximorfona sólido, e, alcaloide de oximorfona sólido
WO2015107472A1 (en) 2014-01-15 2015-07-23 Rhodes Technologies Process for improved oxymorphone synthesis
EP3094634A1 (en) 2014-01-15 2016-11-23 Rhodes Technologies Process for improved oxycodone synthesis
EP3166948A1 (en) * 2014-07-09 2017-05-17 Rhodes Technologies Inc. Reduction of alpha, beta-unsaturated ketone levels in morphinan derivative compositions
US20160052932A1 (en) 2014-08-25 2016-02-25 Johnson Matthey Public Limited Company Processes for Making Opioids Including 14-Hydroxycodeinone and 14-hydroxymorphinone
US20160340362A1 (en) * 2015-05-20 2016-11-24 Noramco, Inc. Process For The Preparation Of Oxymorphone Freebase
ES2701855T3 (es) 2016-05-31 2019-02-26 Alcaliber Investig Desarrollo E Innovacion Slu Proceso para la obtención de 3,14-diacetiloximorfona a partir de oripavina
US10935314B2 (en) * 2019-03-21 2021-03-02 Evan Prout Heating values of cellulosic waste
CN113493460A (zh) * 2020-03-20 2021-10-12 江苏恩华药业股份有限公司 盐酸羟考酮杂质b的制备方法
JP2023548356A (ja) 2020-11-02 2023-11-16 ローズ テクノロジーズ ノルオキシモルホンを精製するための方法
US11247999B1 (en) 2021-07-02 2022-02-15 Joseph DeGraw Facile conversion of morphine to normorphine

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772270A (en) 1954-10-21 1956-11-27 M J Lewenstein 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone
US3173876A (en) 1960-05-27 1965-03-16 John C Zobrist Cleaning methods and compositions
NL271831A (forum.php) 1960-11-29
US3276586A (en) 1963-08-30 1966-10-04 Rosaen Filter Co Indicating means for fluid filters
NL6714885A (forum.php) 1967-11-02 1969-05-06
US3541006A (en) 1968-07-03 1970-11-17 Amicon Corp Ultrafiltration process
US3541005A (en) 1969-02-05 1970-11-17 Amicon Corp Continuous ultrafiltration of macromolecular solutions
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4861598A (en) 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
DE3812567A1 (de) 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
US5215758A (en) 1991-09-11 1993-06-01 Euroceltique, S.A. Controlled release matrix suppository for pharmaceuticals
US5472712A (en) 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5286493A (en) 1992-01-27 1994-02-15 Euroceltique, S.A. Stabilized controlled release formulations having acrylic polymer coating
US5273760A (en) 1991-12-24 1993-12-28 Euroceltigue, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5324351A (en) 1992-08-13 1994-06-28 Euroceltique Aqueous dispersions of zein and preparation thereof
ATE419039T1 (de) 2001-07-18 2009-01-15 Euro Celtique Sa Pharmazeutische kombinationen von oxycodon und naloxon
US6864370B1 (en) 2003-06-05 2005-03-08 Zhaiwei Lin Process for manufacturing oxycodone
US20050203115A1 (en) * 2004-03-10 2005-09-15 Sancilio Frederick D. Narcotic-NSAID ion pairs
TW201509943A (zh) * 2004-03-30 2015-03-16 Euro Celtique Sa 含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽之組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
SK286087B6 (sk) * 2004-08-18 2008-03-05 Zentiva, A. S. Spôsob prípravy oxykodonu
GB0421149D0 (en) 2004-09-23 2004-10-27 Johnson Matthey Plc Preparation of oxycodone
US8703099B2 (en) * 2005-02-24 2014-04-22 Dr Pharma Nova, Llc Registry method and control system for DEA schedule II-V medicines
WO2006138020A2 (en) 2005-06-16 2006-12-28 Mallinckrodt Inc. A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
KR100753432B1 (ko) 2005-11-08 2007-08-31 경희대학교 산학협력단 다결정 실리콘 및 그의 결정화 방법
US20070117826A1 (en) * 2005-11-23 2007-05-24 Forest Laboratories, Inc. Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone
AU2007313103C1 (en) * 2006-10-17 2014-01-30 Penick Corporation Process for preparing oxymorphone
WO2008070656A2 (en) 2006-12-04 2008-06-12 Noramco, Inc Process for reducing impurities in oxycodone base
ES2393221T3 (es) * 2006-12-04 2012-12-19 Noramco, Inc. Procedimiento de preparación de oxicodona con niveles reducidos de 14-hidroxicodeinona
GB0624880D0 (en) 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
WO2008118654A1 (en) 2007-03-23 2008-10-02 Mallinckrodt Inc. Improved preparation of oxymorphone from oripavine
US8309727B2 (en) 2007-04-16 2012-11-13 Mallinckrodt Llc Opiate reduction utilizing catalytic hydrogen transfer reaction
US8217204B2 (en) 2009-06-03 2012-07-10 Takasago International Corporation Catalyst for asymmetric hydrogenation
WO2011032214A1 (en) * 2009-09-16 2011-03-24 Monash University A method for the n-demethylation of n-methyl heterocycles
EP2377866B1 (en) * 2010-03-23 2014-02-26 Siegfried AG Preparation of low impurity opiates in a continuous flow reactor
CA2802294C (en) * 2010-06-11 2016-05-10 Rhodes Technologies Process for n-dealkylation of tertiary amines
PL2588481T3 (pl) * 2010-07-02 2018-05-30 Johnson Matthey Public Limited Company Sposób syntezy i oczyszczania oksykodonu
EP2590649B1 (en) 2010-07-08 2018-11-28 Alkermes Pharma Ireland Limited Process for the synthesis of substituted morphinans
JP5780933B2 (ja) 2010-12-01 2015-09-16 高砂香料工業株式会社 光学活性メントールの製造方法
AU2013274407B2 (en) 2012-06-11 2017-06-22 Siegfried Ag Improved method of preparing oxymorphone
WO2014013311A1 (en) 2012-07-16 2014-01-23 Rhodes Technologies Process for improved opioid synthesis
CN103113378B (zh) 2013-02-20 2016-04-06 北京华素制药股份有限公司 一种盐酸羟吗啡酮的合成方法
CN103433076B (zh) 2013-09-02 2015-06-24 浙江新和成股份有限公司 一种固载型不对称催化剂及其在不对称氢化反应中的应用
US8846923B1 (en) 2013-12-18 2014-09-30 Cody Laboratories, Inc. Preparation of 14-hydroxycodeinone sulfate
CA2934527A1 (en) 2013-12-18 2015-06-25 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
US10227354B2 (en) 2013-12-18 2019-03-12 Cody Laboratories, Inc. Conversion of oxycodone base to oxycodone hydrochloride
US9062062B1 (en) 2013-12-18 2015-06-23 Cody Laboratories, Inc. Synthesis of oxycodone hydrochloride
WO2015107472A1 (en) 2014-01-15 2015-07-23 Rhodes Technologies Process for improved oxymorphone synthesis
EP3094634A1 (en) 2014-01-15 2016-11-23 Rhodes Technologies Process for improved oxycodone synthesis

Also Published As

Publication number Publication date
MX363610B (es) 2019-03-28
SG11201407988UA (en) 2015-01-29
US20190367526A1 (en) 2019-12-05
TWI643859B (zh) 2018-12-11
PH12015500089B1 (en) 2015-03-02
KR101946103B1 (ko) 2019-02-08
TW201641502A (zh) 2016-12-01
US10316042B2 (en) 2019-06-11
BR112015000944A2 (pt) 2019-10-15
EP2872516A1 (en) 2015-05-20
KR20150029752A (ko) 2015-03-18
PH12015500089A1 (en) 2015-03-02
EA028092B1 (ru) 2017-10-31
AU2013291725B2 (en) 2016-07-28
JP6236447B2 (ja) 2017-11-22
TWI643860B (zh) 2018-12-11
ES2647949T3 (es) 2017-12-27
AU2016204926A1 (en) 2016-07-28
IN2015DN01165A (forum.php) 2015-06-26
EA201590222A1 (ru) 2015-05-29
JP2015524407A (ja) 2015-08-24
CA2974010A1 (en) 2014-01-23
EP2872516B1 (en) 2017-08-30
CA2879270C (en) 2017-09-05
US20150315203A1 (en) 2015-11-05
AU2013291725A1 (en) 2014-12-18
MX2015000879A (es) 2017-02-14
CA2879270A1 (en) 2014-01-23
CN104470928A (zh) 2015-03-25
WO2014013313A1 (en) 2014-01-23
UA117225C2 (uk) 2018-07-10
TW201416369A (zh) 2014-05-01
CN104470928B (zh) 2017-08-11
CO7180188A2 (es) 2015-02-09
HK1210170A1 (en) 2016-04-15
AR092858A1 (es) 2015-05-06
US20230130617A1 (en) 2023-04-27
NZ628699A (en) 2016-05-27
IL236710A0 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
IL236711B (en) Process for preparing 17-disubstituted derivatives of 3-methoxy-6-oxo-8,7-didhydro-14-hydroxy-morphinan sulfates
ZA201500603B (en) Process
IL231591A (en) Preserved benzyl indazoles, a process for their preparation and use
GB201216921D0 (en) Process
IL236710B (en) Process for preparing 17-disubstituted derivatives of 3-oxy-6-oxo-8,7-didhydro-14-hydroxy-morphinan sulfates
GB201207997D0 (en) Process
GB201214326D0 (en) Process
GB201500761D0 (en) Process
EP2814797A4 (en) PROCESS FOR 1,3,3,3-TETRAFLUORPROPES
GB201219224D0 (en) Process
GB201318062D0 (en) Process
PL2914574T3 (pl) Nowy sposób
EP2852660A4 (en) PROCESS
ZA201502344B (en) Process
SG11201503421WA (en) Process for producing phenol
ZA201501030B (en) Catalyst preparation process
SG11201500058VA (en) Process for producing phenol
EP2818476A4 (en) PROCESS FOR PREPARING 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-L-FURANIDOSE
IL239654A0 (en) Process for the preparation of 6alpha, 14alpha-ethanomorphinans from 7-beta mutants and 6alpha, 14alpha-ethanomorphinans from 7-beta mutants
IL233626A (en) Process for making chloroamines
GB201317561D0 (en) Process
GB201316604D0 (en) Process
EP2831054A4 (en) IMPROVED PROCESS FOR THE PRODUCTION OF (S) -EQUOL
PL399603A1 (pl) Sposób wytwarzania 3β,15α-dihydroksy-5α-androst-17-onu
GB201216145D0 (en) Process for modifying membranes

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed